Risk of Urinary Adverse Effects of Bevacizumab Therapy in Patients With Ovarian Cancer: A Systematic Review and Meta-Analysis. Arch Ital Urol Androl 2025, 97 (4). https://doi.org/10.4081/aiua.2025.14659.